Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_assertion description "[Rofecoxib is a specific COX-2 inhibitor able to exert antiproliferative activity against colorectal cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_assertion evidence source_evidence_literature NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_assertion SIO_000772 22002318 NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_assertion wasDerivedFrom befree-2016 NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_assertion wasGeneratedBy ECO_0000203 NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.
- befree-2016 importedOn "2016-02-19" NP931418.RADRo0F76Cr1ejfPYOyMRgL7BvuefoJCRu0Mx_pzGrLZg130_provenance.